Previous 10 | Next 10 |
Noteworthy events during the week of March 24 - 30 for healthcare investors. More news on: Cidara Therapeutics, Inc., Recro Pharma, Inc., Autolus Therapeutics plc, Healthcare stocks news, , Read more ...
Akari Therapeutics (NASDAQ: AKTX ) +19% on announcing that it had a successful Type B, pre-IND meeting with the FDA. More news on: Akari Therapeutics, Plc, Pareteum Corporation, PAVmed Inc., Stocks on the move, Read more ...
SAN DIEGO , March 13, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage oncology therapeutics company, using a precision medicine approach to develop drugs that target cell division (mitosis) for the treatment of leukemias, lymphomas and solid tumor cancers, annou...
The FDA recently took a big step towards blessing the emerging field of brain-computer interfacing technology, which has broad application in prosthetics and even enhancing the human brain. Visionaries like Elon Musk are betting on the latter happening quickly, and startups like his are de...
NetworkNewsWire Editorial Coverage : After thirty years of development, gene therapy is seeing a surge of progress and profitability. Gene therapies tackle diseases by altering the genetic makeup of patients’ cells. Recent mergers and research developments make this a promising...
SAN DIEGO , March 12, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage oncology therapeutics company, using a precision medicine approach to develop drugs that target cell division (mitosis) for the treatment of leukemias, lymphomas and solid tumor cancers, ...
Globus Maritime (NASDAQ: GLBS ) +109% . More news on: Globus Maritime Limited, Axovant Sciences Ltd., Pyxis Tankers Inc., Stocks on the move, Read more ...
TrovaGene (NASDAQ: TROV ): Q4 GAAP EPS of -$1.09. More news on: TrovaGene, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
SAN DIEGO , March 6, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage oncology therapeutics company, using a precision medicine approach to develop drugs that target cell division (mitosis) for the treatment of leukemias, lymphomas and solid tumor cancers, today ...
Gainers: Arcadia Biosciences (NASDAQ: RKDA ) +83% . Horizon Pharma Public (NASDAQ: HZNP ) +30% . J. C. Penney Company (NYSE: JCP ) +27% . Sequential Brands Group (NASDAQ: SQBG ) +28% . Triple-S Management (NYSE: GTS ) +25% . TG Therapeutics (NASDAQ: TGTX ) +21% . T2 Biosystems ...
News, Short Squeeze, Breakout and More Instantly...
SAN DIEGO , May 7, 2020 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage oncology therapeutics company developing drugs to treat cancers with the greatest medical need for new treatment options, including colorectal cancer, prostate cancer and leukemia, today a...
SAN DIEGO , May 6, 2020 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage oncology therapeutics company developing its drug, onvansertib, to treat cancers with the greatest medical need for new treatment options, including KRAS-mutated colorectal cancer, Zytiga&...
SAN DIEGO , April 28, 2020 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, oncology therapeutics company developing drugs to treat cancers with the greatest medical need for new treatment options, including colorectal cancer, prostate cancer and leukemia, ...